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It remains unclear whether basophils and mast cells
are derived from a common progenitor. Furthermore,
how basophil versus mast cell fate is specified has
not been investigated. Here, we have identified a
population of granulocyte-macrophage progenitors
(GMPs) that were highly enriched in the capacity to
differentiate into basophils and mast cells while re-
taining a limited capacity to differentiate into myeloid
cells. We have designated these progenitor cells
‘‘pre-basophil and mast cell progenitors’’ (pre-
BMPs). STAT5 signaling was required for the differ-
entiation of pre-BMPs into both basophils and mast
cells and was critical for inducing two downstream
molecules: C/EBPa and MITF. We have identified
C/EBPa as the critical basophil transcription factor
for specifying basophil cell fate and MITF as the
crucial transcription factor for specifying mast cell
fate. C/EBPa and MITF silenced each other’s
transcription in a directly antagonistic fashion. Our
study reveals how basophil and mast cell fate is
specified.
INTRODUCTION
Basophils and mast cells share many common characteristics,
such as the expression of a high-affinity immunoglobulin E
(IgE) receptor (FcεR), and they contain many of the same gran-
ules (Galli and Franco, 2008; Marone et al., 2002). However,
these cells also show notable differences. Basophils circulate
in the bloodstream, whereas mast cells reside in tissue. Mature
basophils do not proliferate and have a short lifespan of approx-
imately 60 hr (Ohnmacht and Voehringer, 2009), whereas mature
mast cells can proliferate and have a much longer lifespan of up
to several months (Galli et al., 2008). Functionally, both basophils
andmast cells are the key effectors in type 2 immunity that causeallergic disease and provide protection against parasitic infec-
tions. Accumulated evidence supports the nonredundant role
of basophils in immune regulation, protective immunity, allergy,
and autoimmunity (Karasuyama et al., 2011). Recent success
in using IgE antibody to treat various allergic disorders in humans
supports the importance of FcεR-expressing basophils and
mast cells in human diseases (Busse et al., 2011; Holgate
et al., 2005). Thus, a more comprehensive understanding of
the developmental pathway for basophils and mast cells is of
substantial value.
The hematopoietic hierarchy consists of various stem cells
and progenitors. Long-term repopulating hematopoietic stem
cells (HSCs) are at the top of the hematopoietic hierarchy. These
cells possess the capacity for self-renewal and the potential to
give rise to all types of blood cells. Long-term HSCs can
generate short-term repopulating HSCs, which then give rise
to multiple potential progenitors (MPPs). MPPs, in turn, can
give rise to both common lymphoid progenitors and common
myeloid progenitors (CMPs). CMPs can differentiate into granu-
locyte-monocyte progenitors (GMPs) (Kondo et al., 2003). GMPs
give rise to eosinophil lineage-restricted progenitors (Iwasaki
et al., 2005), basophil lineage-restricted progenitors (BaPs),
neutrophils, and macrophages (Arinobu et al., 2005).
The origin of basophils and mast cells has been a long-stand-
ing, unsolved, and important issue in hematology. By using col-
ony formation assays, two groups have claimed that basophils
develop from a common basophil and eosinophil progenitor
(Denburg et al., 1985; Leary and Ogawa, 1984). Whether baso-
phils and mast cells are derived from a common progenitor
remains a controversial issue. Galli and colleagues found mast
cell lineage-restricted progenitors (MCPs) in the bone marrow
and proposed that MCPs were derived from multiple potential
progenitors (MPPs) instead of CMPs or GMPs (Chen et al.,
2005). Alternatively, Akashi and colleagues showed that both
basophils and mast cells were derived from CMPs and GMPs
(Arinobu et al., 2009); they further showed that basophil-mast
cell progenitors (BMCPs) found in the spleen gave rise to both
basophils and mast cells (Arinobu et al., 2005). However, the
validity of BMCPs as authentic bipotential basophil-mast cell
progenitors has recently been challenged by a study in whichImmunity 39, 97–110, July 25, 2013 ª2013 Elsevier Inc. 97
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Differentiation of Pre-BMPsGalli and colleagues demonstrated that BMCPs gave rise only to
mast cells (Mukai et al., 2012).
Furthermore, the mechanisms by which basophil cell fate
versus mast cell fate is specified remains undetermined. Regula-
tory networks containing primary and secondary determinants of
cell fate have been shown to be critical in making T cell, B cell,
macrophage, and neutrophil cell fate choices in the hematopoi-
etic system (Laslo et al., 2008). For instance, Singh and
colleagues demonstrated that a high dose of a transcription fac-
tor from the ETS family, PU.1, drove GMPs to differentiate into
macrophages (Laslo et al., 2006), whereas a high C/EBPa/
PU.1 ratio directed the differentiation of GMPs into neutrophils
(Dahl et al., 2003). PU.1 induced the secondary determinants
Egr1,2 and Nab-2 to suppress neutrophil cell fate, whereas C/
EBPa induced Gfi to suppressmacrophage cell fate. The actions
of Egr1,2 and Nab-2 and Gfi were found to be directly antago-
nistic to one another (Laslo et al., 2006). Despite the previous
identification of several factors involved in the differentiation of
basophils and mast cells, it remains unclear how these factors
relate to one another in specifying basophil versus mast cell
fate. Thus, STAT5 (Shelburne et al., 2003), GATA1 (Migliaccio
et al., 2003), GATA2 (Tsai and Orkin, 1997), and MITF (Kitamura
et al., 2002; Takemoto et al., 2008) have each been demon-
strated as critical for mast cell differentiation, whereas STAT5
(Ohmori et al., 2009), Runx1 (Mukai et al., 2012), GATA2, and
C/EBPa (Iwasaki et al., 2006) have each been implicated to
play imperative roles in basophil differentiation. It remains
unknown which of the aforementioned factors are the master
determinants for basophil versus mast cell fate.
In this study, we identified a population of granulocyte-
macrophage progenitors (GMPs) that possessed highly enriched
capacity to differentiate into basophils and mast cells while still
retaining a limited capacity to differentiate into myeloid cells.
We have designated these progenitors as pre-basophil and
mast cell progenitors (pre-BMPs). Our analysis revealed that
a regulatory network—composed of STAT5, C/EBPa, and
MITF—plays a critical role in determining basophil versus mast
cell fate. Specifically, the upregulation of both C/EBPa and
MITF in pre-BMPs was STAT5 dependent and expression of
C/EBPa and MITF was mutually exclusive. Dominance of
C/EBPa resulted in the differentiation of pre-BMPs into baso-
phils, whereas dominance of MITF led to the differentiation of
pre-BMPs into mast cells.
RESULTS
A Subset of GMPs in the Bone Marrow Acquires the
Capacity to Produce Type 2 Cytokines
Mature basophils are known to be robust type 2 cytokine-pro-
ducing cells. To determine at which developmental stage the
bone marrow progenitor cells begin to acquire such capacity,
we analyzed Il4-Gfp reporter gene expression in CMPs, GMPs,
BaPs, and mature basophils from the bone marrow of heterozy-
gous IL-4 reporter mice (Il4G4/+ mice) as well as in BMCPs from
the spleen of Il4G4/+ mice (the reported BMCPs were not found
in the bone marrow; hereafter, BMCPs refer to BMCPs in the
spleen) (Arinobu et al., 2005). We found that CMPs did not ex-
press GFP regardless of whether they were stimulated with
PMA and ionomycin (P&I) or not, whereas a subset of GMPs ex-98 Immunity 39, 97–110, July 25, 2013 ª2013 Elsevier Inc.pressed GFP only when stimulated by P&I (Figures 1A and 1B).
BaPs and mature basophils expressed GFP without any P&I
stimulation, but stimulation markedly increased the percentage
of GFP+ BaPs and basophils (Figures 1A and 1B). A small per-
centage of BMCPs also expressed GFP with P&I stimulation
(Figures 1A and 1B). We did not find any difference in the number
of GFP+ GMPs between Il4G4/+ mice and Il4G4/G4 mice (data not
shown). These data suggest that a small subset of GMPs
acquires the capacity to transcribe the Il4 gene.
To search for a surface marker that identifies IL-4-competent
GMPs, we analyzed FcεR1a expression of the GFP+ GMPs
because FcεR1a has been associatedwith IL-4-producing baso-
phils andmast cells. We found that about 70%of FcεR1a+ GMPs
expressed GFP when stimulated with P&I (Figure 1C), whereas
virtually no FcεR1a GMPs expressed GFP when stimulated
(Figure 1C). Thus, FcεR1a served as an appropriate surface
marker for identifying GFP+ GMPs. To determine whether the
FcεR1a+ GMPs represented a novel population of progenitors,
we phenotypically compared them with BaPs or BMCPs. The
identified FcεR1a+ GMPs differed from BaPs by the expression
of c-Kit (Figure 1D). FcεR1a+ GMPs were distinguishable from
BMCPs because the majority of FcεR1a+ GMPs did not express
b7 integrin—only 1.6% of FcεR1a+ GMPs expressed low
amounts of b7 integrin, whereas BMCPs expressed high
amounts of b7 integrin (Figure 1E). In fact, b7 integrin was a use-
ful marker for enriching mast cells but not basophils (Figure S1
available online). An average of 4,929 FcεR1a+ GMPs cells
were found in two tibia and two femur bones per mouse
(Figure 1F).
Mature basophils are known to produce IL-4, IL-5, IL-6, and
IL-13 (Karasuyama et al., 2011). We FACS sorted FcεR1a+
GMPs via the sorting gates shown in Figure 2A. Morphologically,
the FcεR1a+ GMPs resembled immature progenitor cells,
rendering them indistinguishable from the morphology of
FcεR1aGMPs (Figure 2A). We showed that the sorted FcεR1a+
GMPs, but not the FcεR1a GMPs, expressed Il4, Il6, and Il13
mRNA with P&I stimulation (Figure 2B) or IgE cross-linking of
FcεR (Figure 2C). These early progenitors also produced small
amounts of IL-4, IL-6, and IL-13 proteins (Figure 2D). The capac-
ity of FcεR1a+ GMPs to express IL-4, IL-6, and IL-13 was low
compared to that of BaPs and mature basophils (Figures 2B
and 2D) and the capacity to express IL-6 and IL-13 was even
lower relative to that of mast cells (Figures 2B and 2D). In
contrast, the capacity to express IL-4 was comparable to that
of mast cells (Figures 2B and 2D). However, IL-5 mRNA or pro-
tein remained undetectable (data not shown). These data
demonstrate that FcεR1a+ GMPs represent the earliest hemato-
poietic progenitors to acquire the capacity to express type 2
cytokines.
FcεR1a+ GMPs Contain Highly Enriched Common
Basophil and Mast Cell Progenitors
Because FcεR1a+ GMPs phenotypically belong to a subset of
GMPs, it is possible that they are the progenitor cells of BaPs,
MCPs, or BMCPs. To test these possibilities, we differentiated
the FACS-sorted FcεR1a+ GMPs in the presence of IL-3
for 1 day or 3 days and then reanalyzed the FcεR1a+ GMP-
derived cells. We showed that FcεR1a+ GMPs gave rise to
BaPs and MCPs but not BMCPs (Figure S2A). Indeed, after
Figure 1. A Subset of GMPs Begins to Ac-
quire the Capacity to Express the Il4 Re-
porter Gene
(A) FACS analysis of GFP expression in progenitors
of the bone marrow or the spleen prepared from
Il4G4/+ mice. The numbers inside the FACS
plots indicate the percentage within the gated
populations.
(B) The percentages of GFP+ cells within the gated
populations (mean ± SD, n = 3).
(C) FACS-sorted GMPs from the bone marrow of
Il4G4/+ mice were stimulated with P&I for 6 hr and
stained with APC-labeled FcεR1a antibody.
(D) c-Kit expression comparison between FcεR1a+
GMPs and BaPs.
(E) b7 expression comparison between FcεR1a+
GMPs and BMCPs in the spleen.
(F) Total number of FcεR1a+ GMPs in two
tibias and two femur bones per mouse (mean ± SD,
n = 6).
Data are representative of three independent ex-
periments with similar results. Also see Figure S1.
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Differentiation of Pre-BMPs5 days of culture in the presence of IL-3 alone or IL-3 in combi-
nation with IL-6, IL-9, and SCF, FcεR1a+ GMPs differentiated
exclusively into basophils andmast cells under both culture con-
ditions (Figure 3A), BaPs gave rise exclusively to basophils, and
BMCPs gave rise mostly to mast cells (Figure 3A). The IL-3, IL-6,
IL-9, and SCF combination did not enhance basophil differentia-Immunity 39, 97tion from BMCPs, a result that is consis-
tent with a recent report (Mukai et al.,
2012). SCF alone was sufficient for
FcεR1a+ GMPs to differentiate into mast
cells although it was much less sufficient
for FcεR1a+ GMPs to differentiate into
basophils (Figure S2D).
Because the highly purified FcεR1a+
GMP populations still contained hetero-
geneous progenitors, we determined
whether both basophils and mast cells
could be derived from a single FcεR1a+
GMP. By a limiting dilution analysis assay,
the colony-forming efficiency for FcεR1a+
GMPs was determined to be 1 out of
every 133 FcεR1a+ GMPs; the colony-
forming efficiency for BMCPs was deter-
mined to be 1 out of every 64 BMCPs
(Figure S2B). In order to grow single
colony-forming progenitor-derived col-
onies, we seeded the sorted progenitors
at a density below the colony-forming fre-
quency (see the Supplemental Experi-
mental Procedures for further explana-
tion). We analyzed single colony-forming
FcεR1a+ GMP-derived colonies (Fig-
ure 3B) or single colony-forming BMCP-
derived colonies (Figure S2C) by FACS
and found that 39% of single colony-
forming FcεR1a+ GMP-derived colonies
contained both basophils and mast cells,17% contained only basophils, and 8% contained only mast
cells (Figure 3C). The number of single FcεR1a+ GMP-derived
colonies that contained both basophils and mast cells repre-
sented a 6-fold enrichment comparedwith single colony-forming
FcεR1a GMP (regular GMP)-derived colonies (Figure 3C).
Comparedwith BMCPs, the FcεR1a+ GMPpopulation contained–110, July 25, 2013 ª2013 Elsevier Inc. 99
Figure 2. FcεR1a+ GMPs Possess the Ability
to Express IL-4, IL-6, and IL-13
(A) The gates for sorting FcεR1a and FcεR1a+
GMPs. The sorted FcεR1a and FcεR1a+ GMPs
were stained with May-Grunwald Giemsa.
(B) The sorted cells were stimulated with P&I for
4 hr. mRNA expression was measured by qPCR
(mean ± SD, triplicates). Abbreviations are as
follows: Ba, basophils; MC, BMMC.
(C) The sorted FcεR1a and FcεR1a+ GMPs were
not cross-linked (NCL) with IgE, cross-linked with
IgE (IgECL), or stimulated with P&I for 4 hr.
(D) The sorted cells were stimulated with P&I
overnight. IL-4, IL-6, and IL-13 proteins were
measured by ELISA (mean ± SD, triplicates).
Data represent two independent experiments with
similar results.
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Differentiation of Pre-BMPsnearly 4 times the number of single progenitors capable of pro-
ducing both basophils and mast cells (Figure 3C). We found
that BMCPs contained highly enriched mast cell-lineage
restricted progenitors (62% of single BMCPs gave rise to mast
cells, Figure 3C). Within the single colony-forming FcεR1a+
GMP-derived colonies or single colony-forming BMCP-derived
colonies, we noted the presence of cells that stained negative
for FcεR1a and positive for CD11b and (or) Gr-1 (Figure 3B),
suggesting that single common basophil-mast cell progenitors
in the FcεR1a+ GMP population also retained the capacity to
differentiate into macrophages and neutrophils when cultured
in semisolid culture media in the presence of IL-3.
FcεR1a+ GMPs showed a reduced capacity to form colonies.
The colony-forming efficiency of FcεR1a+ GMPs reduced to
26.9% and 56.2% of regular GMPs and splenic BMCPs, respec-100 Immunity 39, 97–110, July 25, 2013 ª2013 Elsevier Inc.tively (Figure S2B). We observed that
FcεR1a+ GMPs formed colonies in the
presence of IL-3 and GM-CSF and failed
to form colonies in the presence of
G-CSF, M-CSF, or IL-5 (Figure S2E).
Furthermore, we did not find that FcεR1a+
GMPs to be responsive to IL-25 (data not
shown). Altogether, because it was deter-
mined that FcεR1a+ GMPs were more
mature than GMPs and because FcεR1a+
GMPs possessed great potential to differ-
entiate into basophils and mast cells but
had not yet fully committed into bipotential
basophil-mast cell potential progenitors,
we named FcεR1a+ GMPs pre-basophil-
mast cell progenitors (pre-BMPs).
Pre-BMPs Give Rise to Basophils
and Mast Cells in Vivo
To determine whether pre-BMPs can give
rise to basophils in vivo,we injected FACS-
sorted pre-BMPs into irradiated CD45.1
mice. After 3 days, we found that more
than 60% of the pre-BMP-derived cells in
the bone marrow of reconstituted CD45.1
mice were basophils (Figure 3D). The per-centageof thepre-BMP-derived basophils decreased to approx-
imately 8% at 6 days after reconstitution (Figure S2F) and no
pre-BMP-derived basophils were detected at 1 month after
reconstitution (Figure S2G). We did not find CD45.2+ T cells or
B cells in the CD45.1 mice reconstituted with pre-BMP cells at
1 month after reconstitution (Figure S2G). These data were
consistent with the notion that pre-BMPs do not possess the
ability to self-renew and that basophils have a short lifespan.
The basophil potential of pre-BMPs assessed by the in vivo
method was similar to that measured by the in vitro method (Fig-
ures 3A and 3D), and this potential as measured by the in vivo
method was 12-fold higher than that of BMCPs and 55-fold
higher than that of unsorted bone marrow cells (Figure 3D).
To determine whether pre-BMPs can give rise to mast cells,
we injected FACS-sorted pre-BMPs into irradiated, mast
Immunity
Differentiation of Pre-BMPscell-deficient mice (KitW-sh/W-sh), whose progenitors are unable
to differentiate into mast cells, allowing more efficient pre-
BMP-derived mast cell reconstitution. We found that pre-
BMPs effectively reconstituted mast cells in both the peritoneal
cavity and in the spleen of the reconstituted KitW-sh/W-sh mice
within 5 to 6 weeks (Figures 3E and 3F). The mast cell reconsti-
tution efficiency of pre-BMPs was comparable to that of BMCPs
and was 73-fold higher than that of unsorted bone marrow cells
(Figures 3E and 3F).
To determine the physiological relevance of pre-BMPs, we in-
fected mice with Schistosoma mansoni cercaria, a type of para-
site that induces a strong type 2 immune response, and
observed a 10-fold expansion of pre-BMPs after 7 weeks of
infection (Figure 3G). Consistently, BaPs, basophils, MCPs,
and mast cells were also markedly expanded (Figures 3H, 3I,
3K, and 3L). The percentage of BMCPs in the spleens of infected
mice decreased, yet the total numbers of BMCPs still markedly
increased because the spleens of infected mice were extremely
enlarged (Figure 3J). These data also support the notion that pre-
BMPs are the in vivo progenitors in the production of basophils
and mast cells.
STAT5 Is Imperative for the Differentiation of Pre-BMPs
into Both Basophils andMast Cells but NotMyeloid Cells
STAT5 is a signaling molecule that can be activated by many
cytokines and growth factors (Leonard and O’Shea, 1998). We
previously demonstrated that STAT5 deficiency impaired the
development of multiple lineages, including basophils (Ohmori
et al., 2009). However, the precise role of STAT5 in the differen-
tiation of pre-BMPs into basophils has not yet been determined.
We showed that Stat5a mRNA was upregulated in pre-BMPs
compared with regular GMPs (Figure 4A). To examine the role
of STAT5 in the differentiation of pre-BMPs into basophils and
mast cells, we treated inducible STAT5 knockout (Stat5f/
RosaYFP/YFPMx1-cre) mice and control (Stat5f/+RosaYFP/YFP
Mx1-cre) mice with i.p. injection of poly(I-C) and then waited 21
to 30 days before analysis. poly(I-C) treatment effectively deleted
the Stat5a/b gene (Figure S3A). STAT5 deficiency had no effect
on the number of T cells, B cells, neutrophils, or macrophages in
the spleen (Figures S3B andS3C) and caused a 50% reduction in
the number of pre-BMPs, BaPs, and basophils in the bone
marrow (Figures S3D and S3E). Because STAT5 can be deleted
in any cell at any developmental stage in the in vivo inducible
gene deletion system, the effects of in vivo STAT5 deficiency
on the number of pre-BMPs, BaPs, and basophils might not
reflect the precise role of STAT5 in pre-BMP differentiation. To
address this issue, we combined the in vivo inducible gene
deletion system with prospective FACS sorting. We demon-
strated that the FACS-sorted YFP+ pre-BMPs, prepared from
poly(I-C)-treated Stat5f/RosaYFP/YFPMx1-cre mice but not
from poly(I-C)-treated Stat5f/+RosaYFP/YFPMx1-cre mice, failed
to differentiate into either basophils or mast cells, but they did
differentiate into myeloid cells (Figure 4B). We did not find evi-
dence of STAT5 haploid insufficiency in the differentiation of
pre-BMPs into basophils or mast cells (Figures S3F and S3G).
We showed that STAT5 was imperative for upregulating Il4, Il6,
and Il13 mRNA expression in pre-BMPs (Figure 4C). The role
of STAT5 in the differentiation of basophils and mast cells was
further confirmed via a different Stat5 inducible gene deletionsystem (Figure S3H). These results demonstrate that STAT5
signaling is required for the differentiation of pre-BMPs into
both basophils and mast cells in vitro and is critical in the acqui-
sition of type 2 cytokine-expressing capacity in pre-BMPs.
C/EBPa Is Required for the Differentiation of Pre-BMPs
into Basophils and Is Necessary for Maintaining
Basophil Identity
To search for downstream transcription factors that direct the
differentiation of pre-BMPs into basophils, we examined the
potential role of C/EBPa because it has been implicated in pro-
moting basophil differentiation (Iwasaki et al., 2006). We
observed that Cebpa mRNA in pre-BMPs was upregulated
compared with that of regular GMPs (Figure 5A). We further
showed that upregulation of Cebpa mRNA in pre-BMPs was
STAT5 dependent (Figure 5B) and that overexpression of a
constitutively active Stat5a mutant, cS5F (Moriggl et al., 2005),
transactivated the Cebpa promoter (Figure 5C). C/EBPa has
been established as a crucial transcription factor in the develop-
mental transition from CMPs to GMPs (Zhang et al., 2004).
To determine whether or not C/EBPa is required for the develop-
ment of pre-BMPs, we treated both inducible Cebpa
knockout (Cebpaf/fRosaYFP/creER) mice and control (Cebpa+/+
RosaYFP/creER) mice with tamoxifen and found that the develop-
ment of pre-BMPs was abolished in the bone marrow of
Cebpaf/fRosaYFP/creER mice but not Cebpa+/+RosaYFP/creER
mice (Figure 5D), indicating that C/EBPa is required for pre-
BMP development.
To precisely determine the stage-specific, developmental role
of C/EBPa in the differentiation of pre-BMPs into basophils, we
FACS sorted pre-BMPs from the bone marrow of Cebpaf/f
RosaYFP/creER mice and Cebpa+/+RosaYFP/creER control mice
and cultured them in medium containing methylcellulose in the
presence of both IL-3 and 4-hydroxytamoxifen (4HT), which
induced deletion of the floxed Cebpa gene, for 9 days. In the
absence of C/EBPa, pre-BMPs failed to differentiate into baso-
phils (Figure 5E). Strikingly, we noted that Cebpa/ pre-BMPs
differentiated exclusively into mast cells (Figure 5E). To deter-
mine whether or not C/EBPa is required for BaPs to differentiate
into basophils, we isolated BaPs from the bone marrow of
Cebpaf/fRosaYFP/creER mice and either Cebpaf/+RosaYFP/creER or
Cebpa+/+RosaYFP/creER control mice and cultured them in the
presence of 4HT.We found that approximately 43%ofCebpa/
BaPs differentiated into c-Kit-expressing ‘‘mast cell-like’’ cells
(Figure 5F). No dosage requirement was observed for C/EBPa
in the differentiation of BaPs into basophils (Figure 5F). Even
mature basophils converted into ‘‘mast cell-like cells’’—i.e.,
reduced CD49b expression and increased CD96 expression—
in the absence of C/EBPa (Figure 5G). A key difference between
basophils and mast cells is that mast cells live much longer. We
noticed that after 2 weeks of culture, WT basophils died whereas
the majority of converted cells still lived. Phenotypically,
Cebpa/ basophils completely converted into mast cells after
2 weeks of culture (Figure S4). One of the major characteristics
of basophils, compared with mast cells, is their ability to produce
large quantities of IL-4.We previously reported that C/EBPa acti-
vated Il4 promoter activity (Qi et al., 2011). Thus, we assessed
whether C/EBPawas required for maintaining the ability of baso-
phils to produce IL-4. We showed that C/EBPa bound to the Il4Immunity 39, 97–110, July 25, 2013 ª2013 Elsevier Inc. 101
(legend on next page)
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Figure 4. STAT5 Is Imperative for the Differ-
entiation of Pre-BMPs into Both Basophils
and Mast Cells
(A) Stat5a/b mRNA expression in GMPs (FcεR1a
GMPs), pre-BMPs, and basophils wasmeasured by
qPCR (mean ± SD, triplicates). Data represent two
independent experiments.
(B) YFP+ pre-BMPs were FACS sorted from bone
marrow cells of poly(I-C)-treated mice and cultured
in methylcellulose containing medium in the pres-
ence of IL-3 for 9 days.
(C) YFP+ pre-BMPs were FACS sorted from poly(I-
C)-treated mice and stimulated with P&I for 4 hr.
mRNA was measured by qPCR (mean ± SD, tripli-
cates). Data represent two (B) or three (C) inde-
pendent experiments with similar results. Also see
Figure S3.
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Differentiation of Pre-BMPspromoter, but not to the Il13 promoter, in primary basophils (Fig-
ure 5H) and that IL-4 production by basophils was dramatically
reduced when the Cebpa gene was deleted after 4HT treatment
(Figure 5I). C/EBPa did not appear to be required for IL-13
production (Figure 5I). These results demonstrate that C/EBPa
is not only required for the differentiation of pre-BMPs into
basophils, but is also required for maintaining the identity of
basophils.
C/EBPa Promotes Basophil Molecular Programming
and Simultaneously Represses Mast Cell Molecular
Programing by Directly Inhibiting Mitf Gene
Transcription
To investigate the mechanisms by which C/EBPa drives
basophil differentiation and maintains basophil identity, we
examined whether C/EBPa promotes basophil molecularFigure 3. Pre-BMP Populations Contain Highly Enriched Common Basophil-Mast Cells Proge
(A) FcεR1a+ GMPs, FcεR1a GMPs, and BaPs FACS sorted from BM cells, BMCPs FACS sorted from the
indicated conditions for 5 days. Basophils and mast cells sorted from FcεR1a+ GMPs cultured in IL-3 were
(B) Single colony-forming FcεR1a+ GMP-derived colonies were analyzed by FACS.
(C) Colony composition. Each type of colony was calculated as the percentage of total colonies analyzed.
(D) FACS analysis of CD45.2+ basophils in the BM of pre-BMP-reconstituted CD45.1 recipient mice (mean
(E) FACS analysis of mast cells from the peritoneal cavity of reconstituted Kitw-sh/w-sh mice (mean ± SD, n
(F) Toluidine blue staining of spleen sections from reconstituted Kitw-sh/w-shmice (403; insert, 1003). Mast ce
the average number of mast cells in five different fields (403) randomly selected from the sections of splee
(G–K) FACS analysis of pre-BMPs (G), BaPs (H), basophils (I), and MCPs (K) in the bone marrow or BMCPs in
with S. mansoni for 7 weeks (left), and the total number of cells in two femur bones per mouse or in the sp
(L) Mast cells in the large intestine of uninfected or infected mice were stained with toluidine blue (left, 403; i
cells in five different fields randomly selected from the sections of large intestine (mean ± SD, n = 3).
Data represent three independent experiments with similar results. Also see Figure S2.
Immunity 39, 97programming and simultaneously re-
pressesmast cell molecular programming.
We performed genome-wide gene expres-
sion profiling on basophils and mast cells
and found that 6,798 genes were shared
by both mast cells and basophils; 2,033
genes were expressed 2- to10-fold (log2
1–3.3) higher in basophils (differentially ex-
pressed in basophils, group 2 of Figure 6A);
and 413 genes were expressed greater
than 10-fold (log2 3.3) higher in basophils(highly expressed in basophils, group 1 of Figure 6A).
Conversely, we found that 569 genes were expressed 2- to
10-fold (log2 1 to 3.3) higher in mast cells and 171 genes
were highly expressed in mast cells (greater than 10-fold
[log2 3.3]) (groups 4 and 5 of Figure 6A, respectively). Genes
that were known to be critical in mediating basophil or mast
cell function were represented in the heat map (Figure 6B).
Expression profiles of the 20 genes that were highly expressed
in either basophils or mast cells were verified by qPCR (Fig-
ure S5A) or by FACS (Figure S5B).
Next, we examined which genes depended on C/EBPa for
their expression and which genes were repressed by C/EBPa.
We treated purified basophils prepared from Cebpaf/f
RosaYFP/creER mice and Cebpa+/+RosaYFP/creER control mice
with or without 4HT treatment for 5 days. Gene expression in
the treated basophils was analyzed by microarray analysis.nitors
spleen, and whole BM cells were cultured under the
stained by May-Grunwald Giemsa (403).
± SD, n = 3).
= 3).
lls are indicated by red arrows. The right panel shows
ns (mean ± SD, n = 3).
the spleen (J) of mice uninfected (UI) or infected (IN)
leen (right). Data represent the mean ± SD (n = 5).
nsert, 1003) and shows the average number of mast
–110, July 25, 2013 ª2013 Elsevier Inc. 103
Figure 5. C/EBPa Is Required for the Differentiation of Pre-BMPs into Basophils and Is Necessary for Maintaining Basophil Identity
(A) Cebpa mRNA expression (mean ± SD, triplicates).
(B) Cebpa and Stat5a/b mRNA expression in YFP+ pre-BMPs of poly(I-C)-treated mice as indicated (mean ± SD, triplicates).
(C) Constitutively active Stat5 (cS5F) activated Cebpa promoter luciferase activity (mean ± SD, triplicates).
(D) Pre-BMPs in the bone marrow of the tamoxifen-treated mice were analyzed by FACS 2 weeks after the treatment. YFP+ cells are shown.
(legend continued on next page)
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Differentiation of Pre-BMPsOverall, deletion of Cebpa in basophils resulted in a reduction of
mRNA expression for 248 genes and led to an increase in mRNA
expression for 255 genes (Figure 6C). The majority of the C/EB-
Pa-regulated genes were either differentially or highly expressed
in basophils or mast cells (Figures 6C and 6D). The C/EBPa
dependency of genes shown in Figure 6B is presented in Fig-
ure 6D. Green represents a reduction in mRNA expression and
red represents an increase in mRNA expression. Among
C/EBPa-repressed genes, many were highly expressed in
mast cells, such as Mitf, Mcpt, Kit, and Tph (Figures 6B and
6D). In the absence of C/EBPa, we did not observe enhanced
expression of macrophage or neutrophil genes that were already
expressed in basophils (Cd11b, Gr1, and F4/80), re-expression
of new macrophage genes (Mmp12, Mpg-1, and Msr1)
or neutrophil genes (Ela2, Prtn3, and Lactotransferrin), or
re-expression of T cell, B cell, or eosinophil surface markers
(Table S1), indicating that C/EBPa represses mast cell program-
ming but not other cell-fate programming in committed basophil
progenitors and mature basophils.
C/EBPa could repress many mast cell-specific genes directly
or indirectly by suppressing a master mast cell transcription fac-
tor that promotes transcription of mast cell-specific genes.
Among C/EBPa-repressed genes,Mitf was of particular interest
because it has been shown to play a critical role in mast cell dif-
ferentiation. We found two C/EBPa-binding sites in theMitf gene
promoter region and demonstrated that C/EBPa bound to the
Mitf promoter in basophils but not in mast cells (Figure 6E).
C/EBPa inhibited Mitf promoter-driven luciferase activity (Fig-
ure 6F). Further, when the Cebpa gene was deleted in basophils,
the Mitf gene was re-expressed (Figures 6D and 6G). To deter-
mine whether re-expression of MITF in basophils is sufficient
to promote mast cell-specific gene expression, we overex-
pressed MITF in BaPs and found that overexpression of MITF
alone redirected committed BaPs to differentiate into mast cells
(Figure 6H). These data demonstrate that C/EBPa represses
mast cell programming in committed basophils by directly sup-
pressing Mitf gene transcription (Figure S7).
MITF Directs the Differentiation of Pre-BMPs into Mast
Cells and Is Required for Repressing Basophil
Programming by Directly Inhibiting Cebpa Gene
Transcription
We found that Mitf is one of the downstream STAT5 genes—
upregulation of Mitf was STAT5 dependent (Figure 7A). Overex-
pression ofMITFwas sufficient to drive pre-BMPs to differentiate
into mast cells (Figure 7B). To test whether Mitf is required for
maintaining mast cell identity, we examined whether or not a
Mitf mutant would lead to the acquisition of basophil character-
istics inMitfmutantmast cells. We chose aMitfmutant that has a
mild effect on mast cell development so that we could observe
any potential ‘‘mast cell to basophil’’ switch; specifically, we
selected theMitfwh/wh mutant. Mitfwh/wh mice harbor two copies(E–G) Pre-BMPs (E), BaPs (F), and basophils (G) were FACS sorted from the un
cellulose-containing medium with or without the addition of 4HT for 9 days or co
5 days (G). YFP+ cells are shown for 4HT-treated groups.
(H) ChIP analysis of C/EBPa binding to the Il4 promoter in basophils (Ba) and ma
(I) MACS-sorted basophils were treated with or without 4HT for 5 days. ELISA an
Data represent two (E, H, I) or three (A–D, F–G) independent experiments. Also sof the Mitf gene with a single amino acid mutation at the basic
domain (DNA binding domain), which results in deficient but
demonstrable DNA binding on mast-cell-specific genes (Kim
et al., 1999). We observed that Mitfwh/wh mast cells switched to
‘‘basophil-like’’ cells—i.e., lost c-Kit and IL-4 receptor a chain
expression but gained CD49b expression—after 28 days of
culture (Figure 7C). Mitfwh/wh mast cells also expressed more
Il4 but less Il6 and Il13mRNA than did WTmast cells (Figure 7D).
We profiled the mRNA expression of Cebpa and other basophil-
enriched genes—identified by genome-wide transcription anal-
ysis—and found that Mitfwh/wh mast cells re-expressed high
amounts of Cebpa mRNA and other basophil-enriched genes
(Figure 7E).Mitfwh/wh mast cells did not re-express macrophage-
or neutrophil-specific genes, nor did they re-express T cell, B
cell, or eosinophil surface markers (Figure S6), indicating that
MITF represses basophil molecular programming but not other
cell-fate programming, in mast cells. Knockdown of Cebpa in
Mitfwh/wh mast cells by Cebpa siRNA inhibited the re-expression
of C/EBPa-dependent genes (Figure 7F).
To examine whether MITF directly suppresses Cebpa tran-
scription, we searched and found three MITF binding sites
(E-box) in the Cebpa promoter (Figure 7G). We showed that
MITF was recruited into the Cebpa promoter in mast cells but
not in basophils (Figure 7G). Coexpression of MITF significantly
inhibitedCebpapromoter-driven luciferasegene transcriptionac-
tivity (Figure 7H), indicating that MITF represses basophil molec-
ular programming incommittedmast cells bydirectly suppressing
the critical basophil transcription factor C/EBPa (Figure S7).
DISCUSSION
In this study, we have identified a population of GMPs that
contain highly enriched common basophil and mast cell progen-
itors. These cells are phenotypically distinct from BMCPs, first
reported to be common basophil-mast cell progenitors, found
in spleen. A recent study reported that BMCPs give rise only to
mast cells (Mukai et al., 2012). Our data demonstrate that
BMCPs predominantly give rise to mast cells in vitro and in vivo,
whereas pre-BMPs contain highly enriched common basophil-
mast cell progenitors. Upon in vitro culture, pre-BMPs fail to
express b7 integrin (a marker for both BMCPs and MCPs). This
finding does not support the conjecture that pre-BMPs are pre-
cursors for BMCPs. It is interesting that pre-BMPs retain some
capacity to differentiate into myeloid cells under semisolid cul-
ture conditions. We also note that pre-BMPs show reduced
growth potential compared with conventional GMPs, suggesting
that pre-BMPs are more differentiated than regular GMPs.
Therefore, we propose that pre-BMPs are the precursors of
both BaPs and MCPs in the bone marrow. Consistent with this
proposal, we note that upon infection with Schistosoma
mansoni, the number of pre-BMPs increases dramatically. In
parallel, the number of BaPs andMCPs also increasesmarkedly.treated mice (Cebpaf/f = Cebpaf/fRosaYFP/creER mice) and cultured in methyl-
mplete medium in the presence of IL-3 with or without the addition of 4HT for
st cells (MC).
alysis of IL-4 and IL-13 is shown (mean ± SD, triplicates).
ee Figure S4.
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Figure 6. C/EBPa Promotes Basophil Molecular Programming and Simultaneously Represses Mast Cell Molecular Programming
(A) Genome-wide gene expression profiling was performed on basophils and mast cells by microarray. Five groups of genes are shown in the Venn diagram.
(B) The representative genes in each of five groups are shown in the heat map.
(C) Numbers and percentages of genes in each group that were C/EBPa dependent (indicated by arrow) or C/EBPa repressed (indicated by bar).
(D) The representative genes that were C/EBPa dependent (the log2 +4HT/4HT ratio < 1) or C/EBPa repressed (the log2 +4HT/4HT ratio > 1).
(legend continued on next page)
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Differentiation of Pre-BMPsAlthough our in vitro data do not support that pre-BMPs give rise
to splenic BMCPs, we cannot rule out whether pre-BMPs give
rise to some splenic BMCPs in vivo. We think it is unlikely that
pre-BMPs (a subset of GMPs) exist in the spleen because
GMPs do not normally reside in the spleen. The precise develop-
mental relationship among pre-BMPs, BaPs,MCPs, and BMCPs
can be further defined by lineage-tracking experiments.
Recently, a novel type of innate cell that can produce a large
amount of IL-13 in response to IL-25, IL-33, and parasitic infec-
tion has been identified (Moro et al., 2010; Neill et al., 2010).
They can be identified by flow cytometry as LinSca-1+
c-Kit+, , or loST2+IL-7R+IL-17RB+CD25+CD44+ (Brickshawana
et al., 2011; Moro et al., 2010; Neill et al., 2010). Although innate
type 2 lymphoid cells express stem-progenitor markers, they
represent terminally differentiated effector cells and they do
not possess progenitor activity. Another population of IL-25-
elicited LinSca-1+ cells in gut-associated lymphoid tissue,
named MPPtype2, has been reported (Saenz et al., 2010). Pre-
BMPs differ from the reported MPPtype2 cells in several aspects.
First, MPPtype2 cells have been identified mainly in gut-associ-
ated lymphoid tissue, whereas pre-BMPs have been identified
in the bone marrow. Second, pre-BMPs and MPPtype2 cells are
phenotypically different. MPPtype2 cells contained two types of
cells: one was defined as Linc-Kit+Sca-1+IL-4-GFP (Il4 gene
reporter mice were used) and the other was defined as Linc-
Kit+Sca-1+IL-4-GFP+. Linc-Kit+IL-4-GFP+ cells give rise to
mast cells, whereas Linc-Kit+IL-4-GFP cells give rise to baso-
phils, mast cells, and myeloid cells (basophil-mast-cell-produc-
ing MPPtype2 cells). Pre-BMPs were identified as Linc-Kit+
Sca-1FcεR1a+IL-4-GFP+. The major phenotypical difference
is that pre-BMPs are Sca-1 negative. It remains unclear whether
a single MPPtype2 cell can give rise to both basophils and mast
cells in vitro and whether bulk MPPtype2 cells can generate baso-
phils and mast cells in vivo. Third, the major functional difference
between pre-BMPs and basophil-mast-cell-producing MPPtype2
cells is the ability of pre-BMPs to express IL-4. Finally, we found
that pre-BMPs were not responsive to IL-25. We envision that
one of the advantages of progenitors equipped with the capacity
to produce type 2 cytokines could be that progenitors can
rapidly differentiate into effectors at the site of inflammation.
How basophil versus mast cell fate is specified has been a
long-standing, unsolved issue. It appears that basophil cell fate
andmast cell fate aremutually exclusive (i.e., under normal phys-
iological conditions, the common basophil-mast cell progenitor
differentiates into either a basophil or a mast cell and not a cell
that displays both basophil and mast cell characteristics).
Thus, we hypothesize that the master determinant for basophil
cell fate must promote transcription of a set of basophil-specific
genes that bestow basophil identity and function while simulta-
neously repressing transcription of a set of mast cell-specific
genes that specify mast cell identity and function. Here, we
develop an approach in which we combine prospective FACS(E) C/EBPa-binding sites and ChIP analysis of C/EBPa binding to the Mitf promo
(F) C/EBPa suppressed Mitf promoter luciferase activity (mean ± SD, triplicates)
(G) Re-expression of Mitf mRNA in Cebpaf/f or Cebpa+/+ basophils treated with
complete deletion of the Cebpa gene by 4HT treatment.
(H) Purified BaPs were infected with GFP, C/EBPa, or MITF virus and analyzed 5
Data (E–H) represent two independent experiments. Also see Figure S5 and Tabsorting of defined progenitors with an inducible gene deletion
within the defined progenitor population. This approach allows
us to efficiently delete a gene of interest at a defined develop-
mental stage. We have identified C/EBPa as the critical basophil
transcription factor for specifying basophil cell fate. C/EBPa pro-
moted a set of basophil-specific genes while simultaneously
repressing a set of mast cell-specific genes. Via a retroviral infec-
tion approach, Akashi and colleagues previously reported that C/
EBPa was critical for the differentiation of GMPs into basophils
(Iwasaki et al., 2006). However, they did not observe that C/
EBPa was required for basophil maintenance (Arinobu et al.,
2005). This could be due to the difficulty of deleting the Cebpa
gene at a precise developmental stage via retrovirus.
We have also identified MITF as a crucial transcription factor
for specifying mast cell fate and promoting a set of mast cell-
specific genes, while simultaneously repressing a set of baso-
phil-specific genes. Kitamura et al. (2002) used various mutants
at the Mitf locus to demonstrate the role of MITF in mast cell
development. They have shown that MITF is required for the
expression of many mast cell-specific genes, including cKit
(Kitamura et al., 2002). We report here that MITF also suppresses
many basophil-specific genes while having no effect on genes
that govern T cell, B cell, eosinophil, neutrophil, or macrophage
development. Taken together, we have demonstrated that MITF
is the key mast cell transcription factor.
Our experimental data also provide an explanation regarding
how basophil cell fate and mast cell fate are mutually exclusive.
We demonstrated that C/EBPa and MITF silence each other’s
transcription in a directly antagonistic fashion by binding to the
other’s promoter, thus suppressing its respectivepromoter activ-
ity. It is interesting to note that themolecular programing of baso-
phils andmast cells is soclosely intertwined that in theabsenceof
C/EBPa or MITF, basophils could re-express only mast cell-spe-
cific genes or mast cells could re-express only basophil-specific
genes, respectively, but not genes that govern other cell fates.
This finding suggests that the suppression of other cell fate
molecular programming might be mediated by transcriptional
repressors that are commonly expressed in both basophils and
mast cells. A shared molecular signature and a restricted, bidi-
rectional convertibility between basophil and mast cell also
strongly support that basophils and mast cells are progenies
from a common progenitor. A better understanding of how
C/EBPa andMITF specify basophil versus mast cell fate through
directmutual repression provides amodel system to facilitate our
understanding of cell fate determination in other cell types.EXPERIMENTAL PROCEDURES
Mice
Mouse strains and sources are listed in the Supplemental Experimental Proce-
dures. All animal experiments were approved by the National Jewish Health
Institutional Animal Care and Use Committee.ter (mean ± SD, triplicates).
.
or without 4HT for 5 days (mean ± SD, triplicates). The right panel indicates a
days after infection. GFP+ cells are shown.
le S1.
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Figure 7. MITF Directs the Differentiation of Pre-BMPs into Mast Cells and Is Required for Repressing Basophil Programming
(A) The sorted YFP+ GMPs from poly(I-C)-treated mice were cultured for 2 or 3 days in the presence of IL-3. Mitf and Stat5a/b mRNA were measured by qPCR
(mean ± SD, triplicates).
(B) Pre-BMPs were infected with GFP or MITF virus. Cells were analyzed 5 days after infection. GFP+ cells are shown.
(C) BM cells from Mitf wh/wh and C57BL/6 mice were cultured in complete IDMEM in the presence of IL-3 for 28 days.
(D) WT and Mitf wh/wh BMMCs were stimulated with P&I for 4 hr. Il4, Il6, and Il13 mRNA was measured by qPCR (mean ± SD, triplicates).
(E) mRNA expression of Cebpa and a set of basophil and mast cell genes in the cultured BMMCs were analyzed by qPCR (mean ± SD, triplicates). The numbers
indicate fold of difference in mRNA expression between WT and Mitfwh/wh mast cells.
(legend continued on next page)
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Differentiation of Pre-BMPsFACS Analysis and Sorting
Cells prepared from various tissues or cell cultures were stained with
fluorochrome-labeled antibodies. Stained cells were acquired by CyAN
(DakoCytomation) and analyzed with FlowJo software (Tree Star). Cell sorting
was carried out with a Moflo machine (DakoCytomation). A more detailed
description of cell surface markers used to define various progenitors is
included in the Supplemental Experimental Procedures.
In Vitro Differentiation of Progenitors
Various progenitors were isolated by FACS sorting and seeded in semisolid
medium supplemented with IL-3 (20 ng/ml) for 7–9 days or in complete IDMEM
in the presence of IL-3 (20 ng/ml) or IL-3 in combination with IL-6 (20 ng/ml),
IL-9 (40 ng/ml), and SCF (50 ng/ml) for indicated periods of time. A more
detailed procedure for semisolid culture has been described in the Supple-
mental Experimental Procedures.
Generation of Chimeric Mice
For in vivo analysis of donor-derived basophils, FACS-sorted CD45.2+ progen-
itors were injected into lethally irradiated CD45.1 congenic recipient mice
intravenously. After 3 days, the bone marrow cells of the reconstituted mice
were analyzed by FACS. For the in vivo analysis of donor-derived mast cells,
FACS-sorted progenitors were injected into lethally irradiated KitW-sh/W-sh
mice (Chen et al., 2005). After 5 to 6 weeks, peritoneal cells and spleens of
the reconstituted mice were analyzed.
Statistical Analysis
All of the error bars in this report represent SDs. For ELISA or qPCR analyses,
means ± SDs were derived from triplicate measurements of one experiment.
Pooled data are indicated in the figure legends. The difference between two
samples was analyzed with Student’s t test.
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE41596.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2013.06.012.
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